Akebia Therapeutics (NASDAQ:AKBA) Earnings Information
Akebia Therapeutics last released its quarterly earnings results on February 24th, 2021. The biopharmaceutical company reported ($0.60) EPS for the quarter, missing analysts' consensus estimates of ($0.40) by $0.20. The company earned $56.70 million during the quarter, compared to analyst estimates of $47.86 million. Akebia Therapeutics has generated ($1.63) earnings per share over the last year. Akebia Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 4th, 2021 based off prior year's report dates.
Akebia Therapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Akebia Therapeutics (NASDAQ:AKBA) Earnings Estimates
2021 EPS Consensus Estimate: ($1.54)
2022 EPS Consensus Estimate: ($0.52)
Akebia Therapeutics (NASDAQ AKBA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)